SIK2 kinase synthetic lethality is driven by spindle assembly defects in FANCA-deficient cells.

Saved in:
Bibliographic Details
Title: SIK2 kinase synthetic lethality is driven by spindle assembly defects in FANCA-deficient cells.
Authors: Chan KK; Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA., Abdul-Sater Z; Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA., Sheth A; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA., Mitchell DK; Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA., Sharma R; Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA., Edwards DM; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA., He Y; Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA., Nalepa G; Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA.; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA., Rhodes SD; Division of Pediatric Hematology-Oncology, Indiana University School of Medicine, Indianapolis, IN, USA., Clapp DW; Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA.; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA., Sierra Potchanant EA; Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA.
Source: Molecular oncology [Mol Oncol] 2022 Feb; Vol. 16 (4), pp. 860-884. Date of Electronic Publication: 2021 Jun 28.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-0261
DOI:10.1002/1878-0261.13027